TRENDING :  Market Movers  |  Top 50   AAPL (-0.23%)    FB (-0.89%)    KO (-0.77%)    AMZN (-0.91%)    UGAZ (4.96%)    VXXB (-3.5%)    MGM (3.07%)    MDB (1.02%)    KRE (2.17%)    AMD (2.38%)    ABMD (1.19%)    AA (0.25%)    IVC (12.08%)    HTGM (2.18%)    GOOS (-2.76%)    GH (4.51%)    GEVO (1.66%)    FUV (-31.27%)    FCEL (12.84%)    DIS (1.75%)    DGAZ (-4.98%)    CRON (2.26%)    CRM (-0.27%)    CGC (3.13%)    CAT (2.7%)

 AGIO - Agios Pharmaceuticals

$59.29 [1.87][3.26%]

Next Earnings

5/3/2019

BMO

Recommend
Trade Idea »



ANALYST RATINGS

Quarterly Rating Chart
Rating

1


1=Strong Buy, 2=Buy, 3=Hold, 4=Underperform, 5=Sell
Price Targets
High $80.00
Low $80.00
Average $80.00
Current $59.29

CompanyAnalyst NamePT ActionActionRatingTargetDate
Leerink SwannAnnouncesUpgradesStrong Buy$80.0002/15/19
*Last 90 days

OPEN RECOMMENDATIONS

No recommendations found.


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $AGIO

Service NameTrader% Success
Shwe MyanmarKyaw Aung75.00 %Subscribe
Alpha Swing TradesJonathan69.00 %Follow

TRENDING ARTICLES



Agios (AGIO) Q4 Earnings Beat, Tibsovo Sales Push Up Stock

02/15/19
Agios Pharmaceuticals Inc AGIO incurred fourth quarter 2018 loss of 1 58 per share narrower than the Zacks Consensus Estimate of a loss of 1 65 and also the year ago loss of 1 81 Total revenues in the reported quarter were 30 million higher than the Zacks Consensus Estimate of

Agios Pharmaceuticals Inc (AGIO) Q4 2018 Earnings Conference Call Transcript

02/14/19
Image source The Motley Fool Agios Pharmaceuticals Inc NASDAQ AGIO Q4 160 2018 Earnings Conference Call Feb 14 2019 8 00 a m ET Contents Prepared Remarks Questions and Answers Call Participants Prepared Remarks

Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Tops Revenue Estimates

02/14/19
Agios Pharmaceuticals AGIO came out with a quarterly loss of 1 58 per share versus the Zacks Consensus Estimate of a loss of 1 65 This compares to loss of 1 81 per share a year ago These figures are adjusted for non recurring items This quarterly report represents an earnings surprise

Agios Pharmaceuticals (AGIO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

02/07/19
The market expects Agios Pharmaceuticals AGIO to deliver a year over year increase in earnings on higher revenues when i t report s results for the quarter ended December 2018 This widely known consensus outlook is important in assessing the company s earnings picture but a powerful